⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OSRH News
OSR Holdings, Inc. Common Stock
Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical Wearables as a Catalyst for Accelerated Commercial Launch
prnewswire.com
OSRH
Vaximm Appoints Sébastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform
prnewswire.com
OSRH
Vaximm, an OSR Company, Receives Binding Term Sheet from BCM Europe for Global Exclusive License of VXM01 with $30M Upfront and Up to $815M in Milestones
prnewswire.com
OSRH
Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings
prnewswire.com
OSRH
Presenting on Emerging Growth Conference 88 Day 2 on December 11; Register to live stream
globenewswire.com
OSRH
SBC
KLXE
GRO
JAGX
XXII
OMEX
CLNN
FFAI
AEM
VOXR
MIGI
NVA
CIA
FUFU
Presenting on Emerging Growth Conference 88 Day 1 on December 10; Register to live stream
globenewswire.com
OSRH
SBC
KLXE
GRO
JAGX
XXII
OMEX
CLNN
FFAI
AEM
VOXR
MIGI
NVA
CIA
FUFU
Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target Following Major Licensing Agreement
newsfilecorp.com
OSRH
Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months
prnewswire.com
OSRH
OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025
prnewswire.com
OSRH
Vaximm AG, an OSR Company, Enters Term Sheet With BCM Europe for Potential VXM01 License with $20M Upfront and Up to $815M in Milestones
prnewswire.com
OSRH